Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,312,825
+$750,346 QoQ
Shares Held
2,762
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#2,038
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. LLY ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,494 | $489,424 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,312,825 | 2,762 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,562,479 | 2,786 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,037,045 | 2,826 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,114,273 | 2,771 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,171,770 | 2,786 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,804,790 | 3,396 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,621,712 | 3,396 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,199,129 | 3,611 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,269,327 | 3,611 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,824,772 | 3,631 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,142,813 | 3,676 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $1,665,640 | 3,101 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,471,659 | 3,138 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,103,408 | 3,213 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,186,419 | 3,243 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $889,859 | 2,752 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $916,598 | 2,827 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $831,045 | 2,902 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $801,314 | 2,901 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $704,702 | 3,050 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $713,348 | 3,108 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $627,341 | 3,358 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $685,152 | 4,058 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $600,517 | 4,057 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $727,481 | 4,431 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,017,649 | 7,336 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||